Promising combo aims to stop triple negative breast cancer from coming back
Disease control
Ongoing
This study tests whether a combination of two chemotherapy drugs, liposomal doxorubicin and carboplatin, can lower the chance of cancer returning in people with early-stage triple negative breast cancer. About 30 participants who have already had surgery will receive the treatmen…
Phase: PHASE2 • Sponsor: Mridula George, MD • Aim: Disease control
Last updated May 11, 2026 20:38 UTC